Oct 27, 2020
Shared decision-making occurs when patients collaborate with their care teams to agree on a health decision that involves multiple treatment options. When patients actively participate in the decision-making process, they are more satisfied with their care and are more likely to follow their treatment plans....
Oct 20, 2020
When biosimilars were first introduced in the U.S. in 2015, it was expected that they would deliver equally effective treatment to patients as their reference products, at a reduced cost for cancer programs and patients. However, it can be difficult to explain to patients that biosimilars may be their best—and...
Oct 13, 2020
Lack of community participation in cancer clinical trials has long been an issue, as has a lack of diversity among participants. On this CANCER BUZZ mini-podcast, learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioritized...